In this study, we aimed to identify factors behind altered fatty acid desaturase activities in NAFLD, following the findings that estimated desaturase enzyme activities in serum and FADS2 mRNA expression in the liver are higher in individuals with NASH [12]. This evidence concerns the gene FADS2 and metabolic dysfunction-associated steatotic liver disease.